ALGN
Strong BuyUnloved QualityFLAGAlign Technology, Inc. · Healthcare · United States · $11.2B · Avg Vol: $124M/d
Unloved Quality: Strong and cheap, but the market has not turned yet. Patience required.
Align Technology has Q78 M66 with an active buyback, but value at V46 is below the calibrated floor. Clear aligners at a full valuation, with the same discretionary-demand exposure as its Chinese peer earlier in this batch.
The ranks quoted here are from the day it was written; today's Quality, Value and Momentum are the bars above.
ABOUT ALIGN TECHNOLOGY, INC.
Read
Align Technology is a global medical device company best known for its Invisalign system of clear aligners for orthodontic treatment, alongside its iTero intraoral scanners. The company holds a dominant market position in the clear aligner segment, protected by extensive intellectual property and a comprehensive ecosystem that includes treatment planning software and professional training. This strong brand recognition and innovative product portfolio establish a significant competitive moat in the dental aesthetics market.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.7B | 3.9B | 4.0B | 4.0B | 2.6% | 4.1B | 4.2B | 4.3B | 3.7% |
| EPS | 4.62 | 5.82 | 5.63 | 5.66 | 7.0% | 5.77 | 6.08 | 6.76 | 9.3% |
| Shares | 77.3M | 75.1M | 73.8M | 71.4M | -7.6% | 71.0M | — | — | — |
| Debt | 126.9M | 126.6M | 119.3M | 114.4M | -3.4% | 120.8M | — | — | — |
| Equity | 3.6B | 3.6B | 3.9B | 4.0B | 4.0% | — | — | — | — |
| Op CF | 568.7M | 785.8M | 738.2M | 593.2M | 1.4% | 755.7M | — | — | — |
| Inv CF | -213.3M | -195.9M | -254.9M | -112.4M | — | — | — | — | — |
| Fin CF | -501.7M | -598.3M | -355.7M | -464.6M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ALGN are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ALGN | Align Technology, Inc.(you) | $11.2B | 85 | Strong Buy |
| SOLV | Solventum Corporation | $15.5B | 83 | Strong Buy |
| BAX | Baxter International Inc. | $13.5B | 73 | Buy |
| ATR | AptarGroup, Inc. | $8.5B | 74 | Buy |
| MMSI | Merit Medical Systems, Inc. | $5.4B | 82 | Strong Buy |
| AVTR | Avantor, Inc. | $9.9B | 70 | Buy |
| NVST | Envista Holdings Corporation | $4.4B | 85 | Strong Buy |
| RMD | ResMed Inc. | $34.7B | 87 | Strong Buy |
| COO | The Cooper Companies, Inc. | $13.9B | 64 | Hold |
| WST | West Pharmaceutical Services, Inc. | $23.7B | 74 | Buy |
Peer medians: ROE -31.0% · P/E 25.0x · Gross margin 58.3%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.